Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T15:27:40.108Z.
Calculation as of: 2026-10-06T15:27:40.108Z.
Quote observation: 2026-10-06T15:25:32.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$1.01B
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$997.87M
EV/FCF Ratio
N/A
TTM Avg
19.90x
3Y Avg
19.90x
5Y Avg
19.90x
Market Cap
$997.50M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.02B
EV/FCF Ratio
60.58x
TTM Avg
62.48x
3Y Avg
62.48x
5Y Avg
62.48x
Market Cap
$1.02B
EV/FCF Ratio
N/A
TTM Avg
99.90x
3Y Avg
55.01x
5Y Avg
50.88x
Market Cap
$987.89M
EV/FCF Ratio
6.65x
TTM Avg
9.54x
3Y Avg
10.29x
5Y Avg
18.38x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Latigo Biotherapeutics Inc. (LTGO) | $1.01B | N/A | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $1.01B | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $997.87M | N/A | 19.90x | 19.90x | 19.90x |
| Aktis Oncology, Inc. (AKTS)vs › | $997.87M | N/A | N/A | N/A | N/A |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $997.50M | N/A | N/A | N/A | N/A |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 60.58x | 62.48x | 62.48x | 62.48x |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.02B | N/A | 99.90x | 55.01x | 50.88x |
| Immatics N.V. (IMTX)vs › | $1.03B | N/A | 4.12x | 4.43x | 22.97x |
| Pacira BioSciences, Inc. (PCRX)vs › | $987.89M | 6.65x | 9.54x | 10.29x | 18.38x |
| Castle Biosciences, Inc. (CSTL)vs › | $1.04B | N/A | 53.87x | 38.43x | 50.64x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
